ImpediMed devices incorporate L-Dex technology and bioimpedance spectroscopy (BIS) to measure and monitor fluid status—noninvasively, easily, quickly and accurately. The L-Dex score represents the difference in the amount of extracellular fluid in an at-risk limb compared to an unaffected limb.
- Hayes S, Cornish B, Newman B. Comparison of methods to diagnose lymphedema among breast cancer survivors: 6-month follow up. Breast Cancer Res Treat. February 1989;(3):221-226.
- Czerniec S, et al. Assessment of lymphedema using measurement tools and self-report. 7th National Lymphedema Network Conference; 2006; Nashville, TN, USA.
- Cornish BH, et al. Early diagnosis of lymphedema using multiple frequency bioimpedance. Lymphology. 2001;34:2-11.
- Ridner SH, et al. A randomized trial evaluating bioimpedance spectroscopy versus tape measurement for the prevention of lymphedema following treatment for breast cancer: interim analysis. Ann Surg Oncol 2019; https://doi.org/10.1245/s10434-019-07344-5.